BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//Telerik Inc.//Sitefinity CMS 14.0//EN BEGIN:VEVENT DESCRIPTION:Available on-demand.\n[Sherlock&trade\; CRISPR SARS CoV-2 Kit i s available for purchase only in the USA.]\nCRISPR-based diagnostic method s are poised to have a significant impact on global health\, and now\, wit h the first FDA-emergency authorized use of CRISPR technology\, this impac t is being brought directly to the fight against the global COVID-19 pande mic. Join us to learn more about how Sherlock Biosciences has been driving CRISPR innovation and how that mission\, with IDT's support\, has led to the Sherlock&trade\; CRISPR SARS-CoV-2 kit. Our speakers will provide an o verview of SHERLOCK CRISPR technology and how it has been adapted for spec ific and sensitive detection of SARS-CoV-2 to increase testing capacity.\n Join IDT as we host this webinar to learn:\n\n how the SHERLOCK CRISPR- based diagnostic tool works\n about Sherlock&trade\; CRISPR SARS-CoV-2 kit and performance\n benefits of the Sherlock CRISPR SARS-CoV-2 kit &n bsp\;\n how the Sherlock CRISPR SARS-CoV-2 kit \;can help your lab increase testing capacity\n\nExplore our CRISPR genome editing solutions\n Overview\nAlt-R CRISPR-Cas9 System\nAlt-R CRISPR-Cas12a (Cpf1) System\nCRI SPR nucleases\nGenome editing detection DTEND;VALUE=DATE:20200624 DTSTAMP:20240328T235922Z DTSTART;VALUE=DATE:20200623 LOCATION: SEQUENCE:0 SUMMARY:Increasing Testing Capacity for COVID-19 with Sherlock CRISPR-Based Diagnostics UID:RFCALITEM638472671625542942 X-ALT-DESC;FMTTYPE=text/html:
Available on-demand.
\n[Sherlock&trad e\; CRISPR SARS CoV-2 Kit is available for purchase only in the USA.]
\ nCRISPR-based diagnostic methods are poised to have a significant impac t on global health\, and now\, with the first FDA-emergency authorized use of CRISPR technology\, this impact is being brought directly to the fight against the global COVID-19 pandemic. Join us to learn more about how She rlock Biosciences has been driving CRISPR innovation and how that mission\ , with IDT's support\, has led to the Sherlock&trade\; CRISPR SARS-CoV-2 k it. Our speakers will provide an overview of SHERLOCK CRISPR technology an d how it has been adapted for specific and sensitive detection of SARS-CoV -2 to increase testing capacity.
\nJoin IDT as we host this webinar to learn:
\nOverview
\nAlt-R CRISPR-Cas9 System
\nAlt-R CRISPR-Cas12a (Cpf1) System
\nCRISPR nucleases
\nGenome editin
g detection